US Stock MarketDetailed Quotes

RNA Avidity Biosciences

Watchlist
  • 28.010
  • -1.210-4.14%
Trading Mar 4 09:49 ET
3.37BMarket Cap-9.69P/E (TTM)

Avidity Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-152.70%-300.87M
-705.24%-99.87M
-78.35%-65.62M
-30.51%-65M
-43.73%-70.38M
12.63%-119.06M
142.11%16.5M
-15.12%-36.79M
-40.12%-49.81M
-65.57%-48.97M
Net income from continuing operations
-51.87%-322.3M
-69.18%-102.26M
-53.55%-80.4M
-50.54%-70.79M
-31.42%-68.86M
-21.97%-212.22M
-19.76%-60.44M
-20.09%-52.36M
-2.92%-47.03M
-53.04%-52.39M
Depreciation and amortization
32.13%2.78M
20.00%738K
25.44%710K
29.87%687K
63.94%641K
51.48%2.1M
61.42%615K
52.97%566K
64.29%529K
24.52%391K
Other non cash items
10.71%3.3M
0.00%824K
11.85%821K
12.57%824K
20.35%828K
8.33%2.98M
21.00%824K
6.53%734K
6.09%732K
-0.15%688K
Change In working capital
-123.81%-14.56M
-108.95%-6.16M
-18.99%6.01M
61.91%-4.06M
-128.51%-10.34M
764.99%61.13M
1,756.06%68.9M
109.76%7.41M
-515.44%-10.66M
-64.91%-4.53M
-Change in prepaid assets
-627.56%-25.06M
-170.16%-8.13M
-192.49%-4.82M
-34.36%-9.58M
-269.55%-2.53M
47.94%-3.44M
10.82%-3.01M
274.09%5.21M
-489.99%-7.13M
171.68%1.49M
-Change in payables and accrued expense
398.80%24.51M
6.44%5.88M
189.56%14.09M
683.93%8.5M
1.47%-3.96M
-76.11%4.91M
-43.20%5.53M
-42.79%4.87M
-170.30%-1.46M
-1,659.30%-4.02M
-Change in other current liabilities
-11.06%-3.7M
-3.06%-944K
-14.06%-933K
-13.66%-932K
-14.60%-887K
-88.88%-3.33M
-20.53%-916K
-8.92%-818K
-226.69%-820K
---774K
-Change in other working capital
-116.38%-10.32M
-104.42%-2.97M
-26.82%-2.34M
-63.99%-2.05M
-142.90%-2.96M
1,330.21%62.99M
3,671.92%67.3M
-49.76%-1.84M
-15.04%-1.25M
-32.21%-1.22M
Cash from discontinued investing activities
Operating cash flow
-152.70%-300.87M
-705.24%-99.87M
-78.35%-65.62M
-30.51%-65M
-43.73%-70.38M
12.63%-119.06M
142.11%16.5M
-15.12%-36.79M
-40.12%-49.81M
-65.57%-48.97M
Investing cash flow
Cash flow from continuing investing activities
-556.72%-854.2M
-225.73%-64.17M
-1,432.49%-482.41M
-696.91%-274.87M
83.27%-32.75M
31.53%-130.07M
757.05%51.04M
-387.95%-31.48M
360.99%46.05M
-11.51%-195.68M
Net PPE purchase and sale
-67.12%-7.07M
-353.77%-3.92M
-84.62%-1.7M
14.63%-531K
49.73%-915K
-49.77%-4.23M
-1.53%-863K
-962.62%-923K
52.95%-622K
-140.11%-1.82M
Net investment purchase and sale
-573.17%-847.14M
-216.09%-60.26M
-1,473.21%-480.71M
-687.81%-274.34M
83.58%-31.83M
32.75%-125.84M
850.26%51.9M
-382.27%-30.56M
385.94%46.67M
-10.96%-193.86M
Cash from discontinued investing activities
Investing cash flow
-556.72%-854.2M
-225.73%-64.17M
-1,432.49%-482.41M
-696.91%-274.87M
83.27%-32.75M
31.53%-130.07M
757.05%51.04M
-387.95%-31.48M
360.99%46.05M
-11.51%-195.68M
Financing cash flow
Cash flow from continuing financing activities
1,170.30%1.19B
-56.97%13.72M
856,060.00%342.46M
1,046.27%446.72M
1,596.12%389.45M
-72.89%93.86M
-86.91%31.89M
-99.90%40K
0.48%38.97M
-4.78%22.96M
Net common stock issuance
990.67%1B
-554.94%-141.9M
--465.15M
1,036.43%433.05M
988.37%244.24M
-73.39%91.74M
-87.17%31.19M
--0
-0.46%38.11M
-6.90%22.44M
Proceeds from stock option exercised by employees
8,917.77%191.81M
22,099.57%155.62M
46,662.50%18.71M
-14,848.27%-127.72M
27,823.85%145.2M
52.80%2.13M
21.70%701K
-86.80%40K
72.17%866K
5,100.00%520K
Cash from discontinued financing activities
Financing cash flow
1,170.30%1.19B
-56.97%13.72M
856,060.00%342.46M
1,046.27%446.72M
1,596.12%389.45M
-72.89%93.86M
-86.91%31.89M
-99.90%40K
0.48%38.97M
-4.78%22.96M
Net cash flow
Beginning cash position
-45.58%185.38M
333.98%372.98M
275.25%578.55M
296.51%471.7M
-45.58%185.38M
6.22%340.65M
-40.30%85.95M
22.99%154.18M
-14.88%118.96M
6.22%340.65M
Current changes in cash
124.01%37.29M
-251.18%-150.32M
-201.28%-205.56M
203.43%106.85M
229.15%286.32M
-878.37%-155.27M
-49.45%99.43M
-466.97%-68.23M
344.44%35.21M
-22.52%-221.69M
End cash Position
20.11%222.66M
20.11%222.66M
333.98%372.98M
275.25%578.55M
296.51%471.7M
-45.58%185.38M
-45.58%185.38M
-40.30%85.95M
22.99%154.18M
-14.88%118.96M
Free cash flow
-149.76%-307.94M
-763.68%-103.79M
-78.50%-67.32M
-29.95%-65.54M
-40.38%-71.3M
11.36%-123.29M
139.06%15.64M
-18.40%-37.71M
-36.78%-50.43M
-67.44%-50.79M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -152.70%-300.87M-705.24%-99.87M-78.35%-65.62M-30.51%-65M-43.73%-70.38M12.63%-119.06M142.11%16.5M-15.12%-36.79M-40.12%-49.81M-65.57%-48.97M
Net income from continuing operations -51.87%-322.3M-69.18%-102.26M-53.55%-80.4M-50.54%-70.79M-31.42%-68.86M-21.97%-212.22M-19.76%-60.44M-20.09%-52.36M-2.92%-47.03M-53.04%-52.39M
Depreciation and amortization 32.13%2.78M20.00%738K25.44%710K29.87%687K63.94%641K51.48%2.1M61.42%615K52.97%566K64.29%529K24.52%391K
Other non cash items 10.71%3.3M0.00%824K11.85%821K12.57%824K20.35%828K8.33%2.98M21.00%824K6.53%734K6.09%732K-0.15%688K
Change In working capital -123.81%-14.56M-108.95%-6.16M-18.99%6.01M61.91%-4.06M-128.51%-10.34M764.99%61.13M1,756.06%68.9M109.76%7.41M-515.44%-10.66M-64.91%-4.53M
-Change in prepaid assets -627.56%-25.06M-170.16%-8.13M-192.49%-4.82M-34.36%-9.58M-269.55%-2.53M47.94%-3.44M10.82%-3.01M274.09%5.21M-489.99%-7.13M171.68%1.49M
-Change in payables and accrued expense 398.80%24.51M6.44%5.88M189.56%14.09M683.93%8.5M1.47%-3.96M-76.11%4.91M-43.20%5.53M-42.79%4.87M-170.30%-1.46M-1,659.30%-4.02M
-Change in other current liabilities -11.06%-3.7M-3.06%-944K-14.06%-933K-13.66%-932K-14.60%-887K-88.88%-3.33M-20.53%-916K-8.92%-818K-226.69%-820K---774K
-Change in other working capital -116.38%-10.32M-104.42%-2.97M-26.82%-2.34M-63.99%-2.05M-142.90%-2.96M1,330.21%62.99M3,671.92%67.3M-49.76%-1.84M-15.04%-1.25M-32.21%-1.22M
Cash from discontinued investing activities
Operating cash flow -152.70%-300.87M-705.24%-99.87M-78.35%-65.62M-30.51%-65M-43.73%-70.38M12.63%-119.06M142.11%16.5M-15.12%-36.79M-40.12%-49.81M-65.57%-48.97M
Investing cash flow
Cash flow from continuing investing activities -556.72%-854.2M-225.73%-64.17M-1,432.49%-482.41M-696.91%-274.87M83.27%-32.75M31.53%-130.07M757.05%51.04M-387.95%-31.48M360.99%46.05M-11.51%-195.68M
Net PPE purchase and sale -67.12%-7.07M-353.77%-3.92M-84.62%-1.7M14.63%-531K49.73%-915K-49.77%-4.23M-1.53%-863K-962.62%-923K52.95%-622K-140.11%-1.82M
Net investment purchase and sale -573.17%-847.14M-216.09%-60.26M-1,473.21%-480.71M-687.81%-274.34M83.58%-31.83M32.75%-125.84M850.26%51.9M-382.27%-30.56M385.94%46.67M-10.96%-193.86M
Cash from discontinued investing activities
Investing cash flow -556.72%-854.2M-225.73%-64.17M-1,432.49%-482.41M-696.91%-274.87M83.27%-32.75M31.53%-130.07M757.05%51.04M-387.95%-31.48M360.99%46.05M-11.51%-195.68M
Financing cash flow
Cash flow from continuing financing activities 1,170.30%1.19B-56.97%13.72M856,060.00%342.46M1,046.27%446.72M1,596.12%389.45M-72.89%93.86M-86.91%31.89M-99.90%40K0.48%38.97M-4.78%22.96M
Net common stock issuance 990.67%1B-554.94%-141.9M--465.15M1,036.43%433.05M988.37%244.24M-73.39%91.74M-87.17%31.19M--0-0.46%38.11M-6.90%22.44M
Proceeds from stock option exercised by employees 8,917.77%191.81M22,099.57%155.62M46,662.50%18.71M-14,848.27%-127.72M27,823.85%145.2M52.80%2.13M21.70%701K-86.80%40K72.17%866K5,100.00%520K
Cash from discontinued financing activities
Financing cash flow 1,170.30%1.19B-56.97%13.72M856,060.00%342.46M1,046.27%446.72M1,596.12%389.45M-72.89%93.86M-86.91%31.89M-99.90%40K0.48%38.97M-4.78%22.96M
Net cash flow
Beginning cash position -45.58%185.38M333.98%372.98M275.25%578.55M296.51%471.7M-45.58%185.38M6.22%340.65M-40.30%85.95M22.99%154.18M-14.88%118.96M6.22%340.65M
Current changes in cash 124.01%37.29M-251.18%-150.32M-201.28%-205.56M203.43%106.85M229.15%286.32M-878.37%-155.27M-49.45%99.43M-466.97%-68.23M344.44%35.21M-22.52%-221.69M
End cash Position 20.11%222.66M20.11%222.66M333.98%372.98M275.25%578.55M296.51%471.7M-45.58%185.38M-45.58%185.38M-40.30%85.95M22.99%154.18M-14.88%118.96M
Free cash flow -149.76%-307.94M-763.68%-103.79M-78.50%-67.32M-29.95%-65.54M-40.38%-71.3M11.36%-123.29M139.06%15.64M-18.40%-37.71M-36.78%-50.43M-67.44%-50.79M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.